FDA Import Refusal 799-1470278-1/11/1 — Astellas Pharma Canada Inc
The FDA refused shipment 799-1470278-1/11/1 from Astellas Pharma Canada Inc (Canada) on Apr 14, 2021. The refused product falls under Drugs and Biologics — ADRENERGIC N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 14, 2021
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60CCA99 ADRENERGIC N.E.C.
- Charges
- 75